Detalhe da pesquisa
1.
BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein.
Blood
; 124(22): 3260-73, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25293778
2.
Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.
Clin Cancer Res
; 20(8): 2092-103, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24436473
3.
Threshold levels of ABL tyrosine kinase inhibitors retained in chronic myeloid leukemia cells determine their commitment to apoptosis.
Cancer Res
; 73(11): 3356-70, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23576564